Preclinical and Toxicology Studies of BRD5529, a Selective Inhibitor of CARD9
T. Kottom, K. Schaefbauer, E. M. Carmona, J. E. Yi, A. Limper
This study evaluates the safety and toxicology of BRD5529, a CARD9 inhibitor, in mice, finding no significant adverse effects at tested doses.
bioRxiv · Nov 19, 2021Pharmacology & Toxicology